Catalyst Pharmaceuticals (CPRX) Selling, General & Administrative (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) posted Selling, General & Administrative of $49.32 million for Q1 2026, up 5.1% from $46.91 million a year earlier but down 7.7% from the prior quarter.
Powered by 
Analysis
Catalyst Pharmaceuticals (CPRX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Selling, General & Administrative at Catalyst Pharmaceuticals was $196.16 million, up 10.4% year-over-year; for FY2025, it was $193.75 million, up 9.0% from FY2024.
- Annual Selling, General & Administrative has increased for eight consecutive years, with a five-year compound annual growth rate of 34.4% (FY2020 to FY2025).
- In prior years, Catalyst Pharmaceuticals' Selling, General & Administrative was $177.74 million in FY2024 (+32.9%), $133.71 million in FY2023 (+134.2%), $57.09 million in FY2022 (+15.0%) and $49.63 million in FY2021 (+12.2%).
- Quarterly Selling, General & Administrative has run from a low of $11.53 million in Q2 2021 to a high of $53.42 million in Q4 2025 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last four quarters, with growth averaging 15.9% over the last eight quarters.
- The strongest year-over-year quarter for Selling, General & Administrative in the past five years was Q4 2023, with growth of 198.4%; the weakest was Q4 2021, with a decline of 0.9%.
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $53.42 million (Q4 2025), $47.47 million (Q3 2025) and $45.95 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn | 49.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 49.32 Mn |
| Dec 31, 2025 | 53.42 Mn |
| Sep 30, 2025 | 47.47 Mn |
| Jun 30, 2025 | 45.95 Mn |
| Mar 31, 2025 | 46.91 Mn |
| Dec 31, 2024 | 44.19 Mn |
| Sep 30, 2024 | 45.88 Mn |
| Jun 30, 2024 | 40.73 Mn |
| Mar 31, 2024 | 46.94 Mn |
| Dec 31, 2023 | 42.04 Mn |
| Sep 30, 2023 | 33.56 Mn |
| Jun 30, 2023 | 28.40 Mn |
| Mar 31, 2023 | 29.72 Mn |
| Dec 31, 2022 | 14.09 Mn |
| Sep 30, 2022 | 13.65 Mn |
| Jun 30, 2022 | 12.92 Mn |
| Mar 31, 2022 | 16.43 Mn |
| Dec 31, 2021 | 13.23 Mn |
| Sep 30, 2021 | 12.15 Mn |
| Jun 30, 2021 | 11.53 Mn |
API Access
Catalyst Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();